LeMaitre Vascular Inc. (NASDAQ:LMAT) picked up Angiotech Pharmaceuticals Inc.’s (NASDAQ:ANPI) Lifespan vascular graft business for $2.8 million and spiked a distribution deal Angiotech had with former Lifespan owner Edwards Lifesciences Corp. (NYSE:EW). Burlington, Massachusetts-based LeMaitre said it paid a multiple of 1.8 times the Lifespan revenues from the last 12 months for the vascular prosthesis, […]
A group representing former shareholders of Angiotech Pharmaceuticals Inc. (NSDQ:ANPI) subsidiary Quill Medical Inc. are suing both companies. QSR Holdings Inc. alleges that Angiotech concealed damaging information about the sales performance of a Quill product prior to Angiotech's acquisition of the company. It also alleges that Angiotech acted to deliberately reduce future milestone-related payments to QSR. Cleveland's Athersys is an Angiotech partner.
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.